Pharmacological treatment of depression in women with breast cancer: a systematic review

Medicin og biovidenskab

• Amitriptyline 18%
• Antidepressive Agents 54%
• Breast Neoplasms 86%
• Citalopram 18%
• Controlled Clinical Trials 16%
• Depression 89%
• Desipramine 19%
• Fluoxetine 34%
• Guidelines 9%
• Mianserin 43%
• Norepinephrine 12%
• Paroxetine 38%
• Pharmaceutical Preparations 6%
• Pharmacology 90%
• Placebos 31%
• Prospective Studies 19%
• Quality of Life 38%
• Randomized Controlled Trials 20%
• Reboxetine 23%
• Serotonin Uptake Inhibitors 16%
• Systematic Reviews 100%
• Therapeutics 22%
• Tricyclic Antidepressive Agents 35%